香港股市 已收市

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
4.2700+0.0400 (+0.95%)
收市價: 04:00PM EDT
4.2100 -0.06 (-1.41%)
收市後: 04:27PM EDT
全螢幕
正在載入互動式股價圖表...
  • Benzinga

    Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure

    Merrimack Pharmaceuticals Inc's (NASDAQ: MACK) partner announced that Ipsen SA (OTC: IPSEY) reported a primary analysis of the results of the Phase 3 trial of Onivyde (irinotecan liposomal injection)for second-line small cell lung cancer (SCLC). The study did not meet the primary endpoint of overall survival in patients treated with Onivyde versus topotecan. However, a doubling of the secondary endpoint of objective response rate (ORR) in favor of Onivyde was observed. The safety and tolerabilit